|
Index of reports
> Death (71)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 71 Next >>
Possible Cancidas side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Death, Cytolytic Hepatitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: 250 mg, qd
Indication: Systemic Candida
Start date: 2012-04-08
End date: 2012-04-22
Cancidas
Dosage: 70 mg, qd
Start date: 2012-03-22
End date: 2012-04-08
Cancidas
Dosage: 70 mg, qd
Indication: Systemic Candida
Start date: 2012-04-20
End date: 2012-04-22
Tienam IV
Dosage: 500 mg, q6h
Indication: Septic Shock
Start date: 2012-04-18
End date: 2012-04-22
Other drugs received by patient: Magnesium Sulfate; Targocid; Nexium; Norepinephrine; Fosfomycin
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Other drugs received by patient possibly interacting with the suspect drug:
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Colistin; Gentamicin; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a individual with unspecified qualification from Ireland on 2012-08-06
Patient: 15 year old female
Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Cyclosporine
Dosage: 200 mg; ;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug; ;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: ; tid; iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim
Possible Cancidas side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient:
Reactions: Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, tiw
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-04-01
Cancidas
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, bid
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 2250 mg, qd
Start date: 2012-05-01
End date: 2012-05-01
Vancomycin
Dosage: 2000 mg, qd
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
End date: 2012-05-01
Vancomycin
Dosage: 1800 mg, qd
Start date: 2012-05-01
End date: 2012-06-03
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2012-05-26
End date: 2012-05-31
Vfend
Dosage: 200 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Colistin; Neupogen; Gentamicin
Possible Cancidas side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in female
Reported by a physician from France on 2012-07-27
Patient: female
Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1unit three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Gentamicin
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100mg twice per day
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1g twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Vfend
Dosage: 200mg twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Atgam; Colistine; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: 15 year old female
Reactions: Drug Interaction, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Cyclosporine
Dosage: 200 mg;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: tid;iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: 400 mg;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Filgrastim; Colistin; Atgam
Possible Cancidas side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient:
Reactions: Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, tiw
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-04-01
Cancidas
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, bid
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 2250 mg, qd
Start date: 2012-05-01
End date: 2012-05-01
Vancomycin
Dosage: 1800 mg, qd
Start date: 2012-05-01
End date: 2012-06-03
Vancomycin
Dosage: 1000 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
End date: 2012-05-01
Vfend
Dosage: 200 mg, bid
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Dosage: 200 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Neupogen; Colistin; Gentamicin
Possible Cancidas side effects in female
Reported by a physician from France on 2012-07-20
Patient: female
Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1unit three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Gentamicin
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100mg twice per day
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1g twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Vfend
Dosage: 200mg twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Atgam; Colistine; Neupogen
Possible Cancidas side effects in
Reported by a physician from United States on 2012-07-20
Patient:
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Administration route: Oral
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 75 year old male
Reported by a physician from United States on 2012-07-02
Patient: 75 year old male
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in female
Reported by a physician from Japan on 2012-06-19
Patient: female
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-14
Patient: male
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-14
Patient: male
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in female
Reported by a physician from France on 2012-06-14
Patient: female
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in 14 year old male
Reported by a physician from Spain on 2012-06-04
Patient: 14 year old male
Reactions: Respiratory Disorder, Anaphylactic Reaction, Subcutaneous Emphysema, Acidosis, Pyrexia, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Simplex Virus Test Positive, Decubitus Ulcer, Graft Versus Host Disease in Skin, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Bone Marrow Transplant, Clostridium Test Positive, Hypotension, Complications of Bone Marrow Transplant, Respiratory Distress, Aplasia, Renal Failure, Fungal Test Positive, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Aspergillosis
Start date: 2010-12-01
End date: 2011-03-01
Cancidas
Dosage: iv
Indication: Rhinitis
Start date: 2010-12-01
End date: 2011-03-01
Voriconazole
Dosage: iv
Indication: Prophylaxis
Other drugs received by patient: Cyclophosphamide; Amphotericin B (+) Cholesterol (+) Diste
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-01
Patient: male
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-01
Patient: male
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in female
Reported by a physician from France on 2012-06-01
Patient: female
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in 14 year old male
Reported by a physician from Spain on 2012-05-30
Patient: 14 year old male
Reactions: Respiratory Disorder, Graft Versus Host Disease, Subcutaneous Emphysema, Pyrexia, Acidosis, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Decubitus Ulcer, Simplex Virus Test Positive, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Clostridium Test Positive, Hypotension, Aplasia, Respiratory Distress, Renal Failure, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Rhinitis
Start date: 2010-12-01
End date: 2011-03-01
Cancidas
Dosage: iv
Indication: Aspergillosis
Start date: 2010-12-01
End date: 2011-03-01
Voriconazole
Dosage: iv
Indication: Prophylaxis
Other drugs received by patient: Amphotericin B (+) Cholesterol (+) Diste; Cyclophosphamide
Possible Cancidas side effects in 53 year old female
Reported by a physician from Turkey on 2012-05-29
Patient: 53 year old female
Reactions: Cardio-Respiratory Arrest, Tracheal Stenosis, Pancytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Teobag; Midazolam HCL; Cefuroxime
Possible Cancidas side effects in
Reported by a physician from France on 2012-05-03
Patient:
Reactions: Death, Cytolytic Hepatitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Amphotericin B and Cholesterol and Distearoylphosphatidylglycerol and
Cancidas
Primaxin
Possible Cancidas side effects in 60 year old female
Reported by a physician from Australia on 2012-04-25
Patient: 60 year old female
Reactions: Blood Bilirubin Increased, Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Ambisome
Indication: Candidiasis
Cancidas
Eraxis
Indication: Candidiasis
Other drugs received by patient: Aspirin; Pentoxifylline; Iron (Unspecified)
Possible Cancidas side effects in
Reported by a physician from Singapore on 2012-04-24
Patient:
Reactions: Systemic Candida, Drug Ineffective, Blister
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole; Vancomycin
Page 1 Next >>
|
